Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mangoceuticals (MGRX) Gross Profit (2023 - 2025)

Historic Gross Profit for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $50899.0.

  • Mangoceuticals' Gross Profit fell 3843.19% to $50899.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $283014.0, marking a year-over-year decrease of 3603.39%. This contributed to the annual value of $379964.0 for FY2024, which is 1194.37% down from last year.
  • According to the latest figures from Q3 2025, Mangoceuticals' Gross Profit is $50899.0, which was down 3843.19% from $89948.0 recorded in Q2 2025.
  • Mangoceuticals' Gross Profit's 5-year high stood at $147398.0 during Q1 2024, with a 5-year trough of $50899.0 in Q3 2025.
  • Its 3-year average for Gross Profit is $92216.0, with a median of $82671.0 in 2024.
  • As far as peak fluctuations go, Mangoceuticals' Gross Profit surged by 15769.33% in 2024, and later crashed by 5789.36% in 2025.
  • Over the past 3 years, Mangoceuticals' Gross Profit (Quarter) stood at $142583.0 in 2023, then tumbled by 43.82% to $80103.0 in 2024, then tumbled by 36.46% to $50899.0 in 2025.
  • Its Gross Profit stands at $50899.0 for Q3 2025, versus $89948.0 for Q2 2025 and $62064.0 for Q1 2025.